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Abstract
Background: In the wake of the epidemic of bovine spongiform encephalopathy the British government established a flock of
sheep from which scrapie-free animals are supplied to laboratories for research. Three breeds of sheep carrying a variety of
different genotypes associated with scrapie susceptibility/resistance were imported in 1998 and 2001 from New Zealand, a
country regarded as free from scrapie. They are kept in a purpose-built Sheep Unit under strict disease security and are
monitored clinically and post mortem for evidence of scrapie. It is emphasised that atypical scrapie, as distinct from classical
scrapie, has been recognised only relatively recently and differs from classical scrapie in its clinical, neuropathological and
biochemical features. Most cases are detected in apparently healthy sheep by post mortem examination.
Results: The occurrence of atypical scrapie in three sheep in (or derived from) the Sheep Unit is reported. Significant features
of the affected sheep included their relatively high ages (6 y 1 mo, 7 y 9 mo, 9 y 7 mo respectively), their breed (all Cheviots)
and their similar PRNP genotypes (AFRQ/AFRQ, AFRQ/ALRQ, and AFRQ/AFRQ, respectively). Two of the three sheep showed
no clinical signs prior to death but all were confirmed as having atypical scrapie by immunohistochemistry and Western
immunoblotting. Results of epidemiological investigations are presented and possible aetiologies of the cases are discussed.
Conclusion: By process of exclusion, a likely explanation for the three cases of atypical scrapie is that they arose spontaneously
and were not infected from an exterior source. If correct, this raises challenging issues for countries which are currently
regarded as free from scrapie. It would mean that atypical scrapie is liable to occur in flocks worldwide, especially in older sheep
of susceptible genotypes. To state confidently that both the classical and atypical forms of scrapie are absent from a population
it is necessary for active surveillance to have taken place.
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Background
TSE-free sheep required for research
The bovine spongiform encephalopathy (BSE) epidemic
in the United Kingdom (UK) led to a need for the British
government to commission research on transmissible
spongiform encephalopathies (TSEs) in cattle, sheep and
other species. It became clear, however, that so far as
sheep were concerned, the possibility of scrapie being
present in locally sourced sheep in the UK would compro-
mise such research. Lack of definitive tests to detect
scrapie infection in living animals, and the known long-
term persistence of the infective agent in the environment
[1] also meant that it would be difficult to guarantee any
indigenous British sheep as being free from the disease.
For this reason the Ministry of Agriculture, Fisheries and
Food (MAFF), (which later became Department for Envi-
ronment, Food and Rural Affairs (Defra)), decided to cre-
ate a flock in the UK from which guaranteed scrapie-free
sheep carrying a range of known scrapie-susceptibility
genotypes could be supplied to other establishments for
research on TSEs.
Scrapie and genetic susceptibility
Classical scrapie is a TSE (prion disease) of sheep and
goats which has been diagnosed in many countries of the
world [2]. Atypical scrapie, a new form of TSE, was first
described in Norway in 2003 [3]. Diagnosis of atypical
scrapie is made if a) the Western blotting (WB) test on
brain tissue reveals a recognisable protein band with a
molecular mass of less than 15 kDa, and b) conspicuous
PrPsc immunolabelling is detected by immunohistochem-
istry (IHC) in the cerebellum and in the nucleus of the spi-
nal tract of the trigeminal nerve in the medulla at the obex
level, but is absent in the dorsal motor nucleus of the
vagal nerve [4].
Three important polymorphisms of the PRNP gene asso-
ciated with susceptibility of sheep to classical scrapie are
located at codons 136, 154 and 171 [5]. With regards to
atypical scrapie, genetic testing of Norwegian sheep
affected with the strain referred to as Nor98, as well as
unaffected sheep from the same flocks, revealed that those
with genotypes most susceptible to classical scrapie
seemed unaffected by this atypical strain [3]. Instead it
transpired that atypical scrapie is often linked to the ARR
and AHQ alleles which tend to be associated with moder-
ate to marked resistance to classical scrapie [6]. In addi-
tion, sheep with atypical scrapie have often been found to
carry another polymorphism, with phenylalanine (F),
rather than leucine (L) at codon 141. Thus the haplotype
AF141RQ tends to confer increased susceptibility to atypi-
cal scrapie [7-9].
Importation and biosecurity of the flock
To achieve their objective MAFF/Defra contracted the Vet-
erinary Laboratories Agency (VLA) to import approxi-
mately 1000 sheep from New Zealand. New Zealand was
selected because of its widely recognised status as a coun-
try free from TSE diseases of animals, including scrapie
[2]. In addition, New Zealand's cautious importation pol-
icy has minimised its own risk of importing animals or
animal feed that might carry such diseases. Prior to the
importation of sheep from New Zealand into the UK a
purpose-built facility was constructed at an Agricultural
Development and Advisory Service (ADAS; now known as
'ADAS UK Ltd.') arable farm in East Anglia. In this paper
the facility is referred to as the 'Sheep Unit'. Selection of
the location of the Sheep Unit was based on the knowl-
edge that a) the sheep population in that area is among
the lowest in the UK, b) no livestock had been kept on the
land for at least the previous 34 years, and c) manure had
not been applied to the fields for at least the same period.
An initial importation to establish the breeding flock took
place in February 1998 and a second to expand the flock
to approximately 800 ewes took place in July 2001. On
both occasions a Boeing 747 was specifically chartered,
enabling import of approximately 1000 sheep each time
(1036 in 1998 and 967 in 2001). Precautions to maintain
TSE-free status during their journeys included confine-
ment of the sheep within their transit crates for the whole
time from Auckland, New Zealand, to their delivery into
the Sheep Unit. Some of the imported sheep were sent out
from the Unit for research soon after importation clear-
ance had been completed, but the remainder were used to
establish the breeding flock.
Risk assessments were carried out before the Sheep Unit
was established to identify potential sources of pathogens,
including TSE agents, which might gain access to the flock
and invalidate the TSE-free status of the sheep. Personnel
working at or visiting the Unit, entry of vehicles, equip-
ment, food, bedding, veterinary drugs, pests, wildlife and
many other factors were taken into account. Standard
operating protocols, were written, which cover all materi-
als, equipment and personnel entering the Unit, and these
have been consistently applied, as a biosecurity shield.
The Unit operates to ISO 9001:2000 standard.
The sheep are also tested regularly for a range of specified
diseases including maedi/visna, chlamydial enzootic
abortion, border disease, ovine Johne's disease and
caseous lymphadenitis. Food and bedding are obtained
from pastures in the UK that are known to have been free
from potential TSE contamination for at least 25 years,
and certain dietary and pharmaceutical items, such as ewe
milk replacer and vaccines, are brought in from New Zea-
land. All equipment is purchased new, dedicated to the
Unit and remains in the Unit. All of the sheep are individ-
ually identified and detailed electronic records are kept of
procedures and events within the Unit.BMC Veterinary Research 2009, 5:8 http://www.biomedcentral.com/1746-6148/5/8
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Breeding within the Sheep Unit
The flock contains the three breeds: Suffolk, Cheviot and
Poll Dorset. As there is no ARH allele in the flock, it is pos-
sible by breeding to produce only ten of the possible 15
PrP genotypes. To increase production of homozygous
animals and to reduce unwanted genotypes, any hetero-
zygous females are mainly used as recipients (surrogates)
for homozygous embryos. Table 1 gives the numbers of
ewes of different breeds and of different PrP genotypes
(homozygous at codons 136, 154, 171) that were present
in the Sheep Unit in May 2002, ten months after the sec-
ond importation. From 2006 some of the breeding ani-
mals have had the full open reading frame sequenced
identifying the haplotype AF141RQ in the Cheviot breed
but not the Suffolk or Dorset breeds. Due to the numbers
of sheep produced by the unit, and the cost, this tech-
nique it is not routinely performed.
Guaranteed scrapie-free sheep of the ten genotypes are
routinely supplied for Defra-funded or Defra-approved
research projects, thereby enabling the UK government's
research objectives to be achieved. As of 1 January 2008,
over 4,700 such sheep had been supplied for research pur-
poses. The flock has also supplied control materials such
as blood for research, and it has the potential to supply
cryobanked semen and embryos as well.
The Sheep Unit is closed to all but sheep (and, if ever nec-
essary, semen and embryos) sourced from New Zealand,
so, where possible, a family breeding system is usually
undertaken, with five unrelated ram lines being used in
successive years (in each breed/homozygous genotype
combination) to minimise inbreeding. This is facilitated
by the collection, freezing and storage of semen within the
Unit. In addition to natural breeding, artificial insemina-
tion and embryo transfer have taken place in all breeding
seasons to enable researchers' demands for certain geno-
types to be met.
Health monitoring in the Sheep Unit
All casualties and most of the mature sheep culled from
within the Sheep Unit are subjected to general post mor-
tem examination at either VLA Weybridge or VLA Bury St.
Edmunds, UK. The brains of young lambs are considered
unlikely to provide evidence of classical scrapie infection
if examined, but, apart from these, the brains of other cas-
ualties and flock management culls, and also those of
many of the sheep sent out from the Unit for research, are
subjected to statutory diagnostic tests for scrapie at VLA
Weybridge, and material retained for future reference. In
June 2006 a recently lambed homebred ewe (G320) at the
Sheep Unit showed signs of blindness, general malaise
and a tendency to walk in circles. She was unresponsive to
treatment, and in September 2006 was culled after her
lamb was weaned. Post mortem examination revealed
that she had atypical scrapie. Subsequent investigations
revealed two further cases of the same disease in sheep
associated with the Unit which had been supplied to other
establishments for research.
This report gives details of these three atypical scrapie
cases, and of the investigations into the possible origins of
the disease following their discovery.
Results
At the time when the data were collected (2006) the total
number of sheep recorded as having been resident in the
Sheep Unit was 5676, of which 2003 (35.3 per cent) were
imported from New Zealand and 3673 (64.7 per cent)
were homebred within the flock. Of these, 808 adults
(14.2 per cent) were still alive within the Unit; 164 were
imported and 644 homebred. Others had been sent to
other institutes for research (many still alive), and a small
number (74) had gone to the abattoir for human con-
sumption, or to the VLA as culls or casualties to be exam-
ined post mortem for scrapie and other diseases. A further
breakdown is given in Table 2.
Table 1: Numbers of ewes of different breeds by homozygous 
genotypes that were in the Sheep Unit in May 2002
Genotype Cheviot Suffolk Poll Dorset
ARQ/ARQ 76 324 29
ARR/ARR 32 108 31
VRQ/VRQ 88 - 13
AHQ/AHQ 15 - -
Total 211 432 73
Table 2: Numbers of sheep at time of data collection in 2006 that 
were recorded as being at the Sheep Unit, or sent for research, 
or to an abattoir, or for examination at the Veterinary 
Laboratories Agency (VLA)
Location/destination Imported Homebred Total
Alive at Sheep Unit 164 644 808
Sent for research 951 1545 2496
Sent to abattoir for slaughter 0 74 74
Culls/casualties sent to VLA 888 1410 2298
Total 2003 3673 5676BMC Veterinary Research 2009, 5:8 http://www.biomedcentral.com/1746-6148/5/8
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If the 808 sheep that were still alive in the Sheep Unit, and
the 74 aged one year or less that had been sent (without
being tested) to the abattoir, are deducted, the remaining
4540 represents the number of sheep potentially available
for testing (see Table 3). However, test results (IHC, WB or
both) were available for only 1041 (22.9 per cent). As
many of the remaining animals had been used in TSE
challenge studies at various institutes, samples were either
unavailable for examination, in some cases because they
were still alive, or were compromised by virtue of having
succumbed to experimental challenge. With regards to
age, only about 40 per cent of sheep with test results were
four or more years old.
Nevertheless, in addition to the index case G320, two fur-
ther cases of atypical scrapie were detected and confirmed
by use of IHC and WB. At the time of testing, these two
additional cases were at other institutes, one having left
the Sheep Unit six months after arrival from New Zealand,
and the other left a few months before being culled, hav-
ing been sent as a surrogate dam carrying a lamb for future
research. Details of the three cases are summarised in
Table 4. It should be noted that all three sheep were rela-
tively old Cheviot ewes with ARQ/ARQ genotypes. Two of
the three were homozygous F/F at codon 141 and the
other was an F/L heterozygote. Only the index case, G320,
showed clinical signs prior to death (see additional file 1).
Histopathological examination of the H&E stained sec-
tions of the obex (medulla at obex level) did not show
vacuolar changes. However, in the brainstem of all three
cases – the two examined by VLA Weybridge, and one
(D337) which was part of an experimental group located
at The Roslin Institute, Edinburgh and identified by VLA
Lasswade (S. Siso, personal communication), IHC
revealed accumulations of PrPsc in the spinal tract nucleus
of the trigeminal nerve, but not in the dorsal motor
nucleus of the vagal nerve. PrPsc was also demonstrated in
the spinocerebellar tract in the case of G320. PrPsc immu-
nostaining in the cerebellum (Fig 1), was noted in all
three cases, and was widespread throughout the brain for
the two cases in which the material was available (G320
and D337).
The molecular profile signals obtained using the 'TeSeE'
(Bio-Rad) WB kit on samples from the three sheep were
quite unlike those of classical scrapie or BSE, but they did
resemble those of atypical scrapie (Nor98), with bands of
molecular mass equal to or less than 15 kDa (Fig. 2). In
the case of Y71 the signal was weaker than that of G320
whilst that of D337 was very faint and consequently has
not been included in Fig. 2. The signal for D337 was, how-
ever, clearly visible using a different extraction procedure
[10] at The Roslin Institute, and this will be reported fully
elsewhere. Diagnosis of atypical scrapie in the three sheep
was made based on the findings with IHC and the WB test.
For the two New Zealand-bred sheep which left the Sheep
Unit, potential exposure to TSEs could not be ruled out.
For Y71, however, such exposure could only have
Table 3: Brain tissue samples tested from sheep of the ten different genotypes in or from the Sheep Unit
PrP genotype Potential no. of sheep of the genotype Sheep with relevant test results (%)
ARR/ARR 793 221 (27.87)
ARR/AHQ 6 1 (16.67)
ARR/ARQ 538 207 (38.48)
AHQ/AHQ 91 33 (36.26)
ARQ/AHQ 32 5 (15.62)
ARQ/ARQ 1651 302 (18.29)
ARR/VRQ 303 47 (15.51)
AHQ/VRQ 31 14 (45.16)
ARQ/VRQ 498 131 (32.11)
VRQ/VRQ 597 80 (13.40)
Total 4540 1041 (22.93)BMC Veterinary Research 2009, 5:8 http://www.biomedcentral.com/1746-6148/5/8
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occurred during the 5 months between leaving the Unit in
January 2007 and culling in June 2007 (Table 4). It is
extremely unlikely that the pathology seen in Y71 could
have developed in such a short interval. By contrast, D337
spent only 6 months at the Sheep Unit and the majority
of its life on a project at the Institute for Animal Health
(subsequently part of The Roslin Institute) where it was
held in biosecure conditions. D337 was challenged with
BSE as part of an experiment [11], however it survived the
infection and was healthy at the time of death. If, in any
of the three affected sheep reported here, another TSE had
been present, it is likely that that TSE, rather than atypical
scrapie, would have been evident from the IHC and WB
test results.
Discussion
It is noteworthy that a clinical presentation was evident
only in the index case, G320, and the other two cases, Y71
and D337, were diagnosed retrospectively after they had
been killed. The latter two had apparently been healthy
immediately prior to their euthanasia and we do not
know if they would have eventually developed clinical
disease. The apparent blindness of sheep G320 prior to
death was unusual in that previous cases of atypical
scrapie have mostly presented with loss of body condi-
tion, sometimes with incoordination [12].
There are several possible origins of these atypical scrapie
cases: exposure from the environment or infected animals
(or, in the case of D337, from the experimental chal-
lenge), and spontaneous development of the disease
within the sheep themselves. From our own investiga-
tions, and the currently available published evidence,
none of these possibilities can be ruled out. We must
point out, however, that if D337 had been infected by
transfusion of blood from the BSE challenged sheep, we
would have expected her IHC and WB test results to be
characteristic of BSE rather than, as was the case, charac-
teristic of atypical scrapie [4].
With regard to the possibility of exposure, we are aware
that the most important risk factor for introduction of
classical scrapie into a flock appears to be the purchase of
infected animals [13] but, as yet, we do not know if this is
Table 4: Details of atypical scrapie cases in sheep in (or from) the Sheep Unit.
Sheep G320 Sheep Y071 Sheep D337
Birth date (and place) 5 May 2000 (Sheep Unit)
Born to a surrogate ewe following 
embryo transfer.
1 September 1999 (New Zealand). 
Imported to UK July 2001
1 September 1997 (New Zealand). 
Imported to UK February 1998
Breed Cheviot Cheviot Cheviot
Sex Female Female Female
Genotype AFRQ/AFRQ AFRQ/ALRQ AFRQ/AFRQ
Breeding history Lambed February 2002; May 2003; 
April 2004; June 2006
Lambed May 2003, May 2005, April 
2006; February 2007
Never bred
Length of stay in Sheep Unit 6 y 4 mo 5 y 2 mo – sent to Sardinia in 
January 2007
6 mo – sent Institute for Animal 
Health in September 1998
Research project (if any) 
which this animal was on
Not on a research project Not on a research project, but 
sent to Sardinia to lamb
Blood transfusion in September 
1999 from a sheep challenged with 
BSE
Date of death 5 Sept. 2006 19 June 2007 2 May 2007
Age at death 6 y 4 mo 7 y 9 mo 9 y 7 mo
Clinical signs Malaise, circling & blindness, ataxia 
(see additional file 1)
None seen before death.
Routine cull.
None seen before death.
End of experiment cull.
Immunocyto-chemistry Positive throughout the brain Positive cerebellum, but medulla 
negative
Positive throughout the brain
Western blot Cortex positive Cerebellum positive Brain weakly positiveBMC Veterinary Research 2009, 5:8 http://www.biomedcentral.com/1746-6148/5/8
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also the case for introduction of atypical scrapie. Experi-
mental transmission of atypical scrapie by intracranial
inoculation of brain homogenate from affected cases has
been demonstrated in transgenic (ovinised) mice [14],
and in sheep with the AHQ/AHQ genotype which suc-
cumbed after a very variable incubation period ranging
from 378 to 1057 days [[9]; unpublished observations].
This leaves open the question of whether the infection can
be transmitted naturally between sheep or via a contami-
nated environment. To our knowledge, experimental
transmission of atypical scrapie has not yet been achieved
by the oral route, although studies are ongoing.
Our retrospective analyses and testing did not enable us to
determine whether atypical scrapie infection was present
among the sheep when they were imported from New
Zealand or whether exposure and/or infection occurred
after the Sheep Unit was established in the UK. With
regard to the latter possibility, we believe that because the
Sheep Unit is completely closed with strict biosecurity
measures, the risk of introducing scrapie from the outside
is very low indeed. At the time of writing (May 2008) only
six cases of classical scrapie (and none of atypical scrapie)
had been confirmed in the county (Cambridgeshire) in
the past ten years, and all of these were beyond a 20 km
radius of the Sheep Unit. Furthermore, all sheep and goats
tested under the Fallen Stock and Abattoir surveys from
holdings in Cambridgeshire have been negative. Accord-
ing to the 2005 agricultural census Cambridgeshire has
Immunohistochemistry (IHC) of cerebellum from G320,  showing widespread immunolabelling thoughout the molecu- lar and granular layers of the cerebellum Figure 1
Immunohistochemistry (IHC) of cerebellum from 
G320, showing widespread immunolabelling though-
out the molecular and granular layers of the cerebel-
lum.
Bio-Rad Western blot (WB) showing samples from G320 (frontal cortex) and Y71 (cerebellum) in duplicate lanes Figure 2
Bio-Rad Western blot (WB) showing samples from G320 (frontal cortex) and Y71 (cerebellum) in duplicate 
lanes. Controls are shown in single lanes as identified in the lane key below. The antibody used to detect PrPsc was mAb Sha31 
as provided in the test kit.
Lane No. Sample identity Tissue type
1 and 12 molecular weight marker marker
2 and 11 BSE +ve control
3 and 10 classical scrapie +ve control
4 and 9 atypical scrapie +ve control
5 and 6 G320 (PG0832/06) (V1975B) frontal cortex
7 and 8 YO71 (PG0604/07) (V2599C) cerebellum
1            2 3       4          5       6 7    8          9      10    11        12
m20.1kD
m 29 kDBMC Veterinary Research 2009, 5:8 http://www.biomedcentral.com/1746-6148/5/8
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less than 31 sheep per km2, which is one of the lowest
densities in the UK, so contact between sheep in the Unit
and other sheep is extremely unlikely. Nevertheless the
Unit is not a high-security laboratory premises but a bar-
riered isolation unit where humans (and occasionally
wildlife such as birds and rodents) come into contact with
its livestock. Therefore we cannot claim that sheep within
the Unit are totally isolated from their environment.
Comprehensive monitoring by IHC and/or WB is under-
taken in animals culled from the flock, and also, where
possible, through follow-up of animals leaving for other
reasons. However, due to the age and genotype structure
of the flock, only a relatively small number of sheep of
genotypes that are now known to be at high risk of atypi-
cal scrapie [5,15] have been tested, and, of those that have
been tested, few were aged four years and over.
Another possible explanation for the three cases of atypi-
cal scrapie is that they arose spontaneously and were not
infected from an external source. The 'spontaneous aetiol-
ogy' hypothesis for atypical scrapie in sheep has been
mentioned by several authors [e.g. [7,10,16,17]] but there
is no published evidence for it, and it would be difficult to
test experimentally. In support of this hypothesis is the
relatively consistent prevalence of atypical scrapie in
national sheep flocks throughout the European Union
(EU), despite significant variations in breed and manage-
ment methods [15]. This suggests that atypical scrapie is
potentially spontaneous at a consistent rate, or, alterna-
tively, that it is poorly contagious.
Although atypical scrapie has been shown to be transmis-
sible by experimental inoculation (see above), if it is a
spontaneous genetic disease it may be similar in origin to
the familial forms of TSE in man such as Gerstmann-
Sträussler-Scheinker syndrome, Creutzfeldt-Jacob disease
and fatal familial insomnia in which the resultant diseases
can subsequently be transmitted experimentally [18,19]).
In a recent article McIntyre [20] refers to the possibility of
a spontaneous aetiology but also restates New Zealand's
position as being free from classical scrapie and other TSEs
of ruminants. For suppliers and users of TSE negative con-
trol sheep and cattle, and of TSE-free biological materials,
the spontaneous aetiology hypothesis raises challenging
nomenclature and certification issues. If the hypothesis is
correct, one would expect sheep of susceptible genotypes
in flocks across the world to be prone to develop atypical
scrapie spontaneously, especially in old age. To state con-
fidently that atypical scrapie is absent from a population,
specific surveillance is required. It is not sufficient to have
shown an absence of the classical disease because atypical
scrapie has been shown to exist in sheep populations in
which classical scrapie has not been detected [21,22]).
Additionally, the low prevalence of atypical scrapie in the
EU, and its widespread recognition only following the
introduction of certain rapid tests into large surveillance
programmes, argues that it may occur below the limit of
detection even in countries that do carry out scrapie sur-
veillance. As reported by Lühken et al. [17] and Moreno et
al. [9], the AFRQ allele appears to confer the highest sus-
ceptibility to atypical scrapie, so the probability of detect-
ing the disease is likely to be greatest in sheep of this
genotype.
Conclusion
In view of the fact that the three sheep affected with atyp-
ical scrapie reported here were carriers of the AFRQ allele,
and were of relatively advanced ages, we are of the opin-
ion that the spontaneous origin explanation is the one
that should be given the most credence.
Disease monitoring, as outlined above, is continuing and
the barriers to introduction of disease from outside the
Sheep Unit will be maintained. However, with the low
recorded incidence of atypical scrapie and the late age at
onset, it will be a challenge to establish the true origin of
the disease in this flock.
Methods
Atypical scrapie was confirmed in the index case (G320)
by the examination of samples of brain by histopathol-
ogy, immunohistochemistry (IHC) and Western immu-
noblotting (WB). Subsequently a history of the flock was
gathered from the database, including breeds, genotypes,
parentage, source flock, siblings, offspring, and the vari-
ous treatments such as vaccinations. Departure dates and
destinations of sheep that had left the Unit were noted
and, where possible, information about their fate was
obtained, including date of death if this had occurred.
Provided that experimental challenge had not compro-
mised its suitability, samples of any archived brain tissues
were also examined for scrapie. Particular emphasis was
given to scrapie results from older sheep, i.e. those aged
four years and over.
Brain tissues examined were primarily those from the
obex but cerebral cortex and cerebellum tissue were used
if obex was not available. These tissues were examined his-
topathologically and tested by IHC and by WB. PrP geno-
types of all sheep were ascertained also.
For histopathology and IHC samples of fixed brain tissue
were trimmed, embedded in paraffin wax and sectioned at
4 μm. Sections for histopathology were stained with hae-
matoxylin and eosin (H&E). Detection of PrPsc by IHC
was performed using the mouse Mab 2G11 (Institute
Pourquier) raised against the ovine PrP peptide sequence
146-R154R171-182, as previously described [23]. For WBBMC Veterinary Research 2009, 5:8 http://www.biomedcentral.com/1746-6148/5/8
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samples of fresh (frozen-thawed) brain tissue were sub-
jected to the 'TeSeE' sheep/goat Western blot (Bio-Rad Cat
No: 355 1169) according to the kit instructions and using
the reagents supplied. Essentially, tissue (0.35 g) from
each sample was ribolysed, purified, proteinase K (PK)
treated and PrPsc  concentrated. Samples were electro-
phoresed, transferred and the signal was detected with the
'Fluor-S MultiImager' (Bio-Rad). For genotyping of the
suspect animals the full open reading frame of the ovine
PrP gene was sequenced from samples of brain tissue, as
previously described [8], in order to identify DNA poly-
morphisms and the resulting PrP protein amino acid
changes at codons 136, 141, 154 and 171.
The sheep described in this paper were controlled under
the UK Animal (Scientific Procedures) Act 1986 (project
licence 70/6194, which was subject to routine ethical
reviews).
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